Rapid Resolution of Suicidal Ideation After a Single Infusion of an N -Methyl- D -Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Objective Suicidal ideation is a medical emergency, especially when severe. Little research has been done on pharmacologic interventions that could address this problem. Ketamine, an N-methyl-D-asparate antagonist, has been reported to have antidepressant effects within hours. We examined the effects of a single dose of ketamine on suicidal ideation in subjects with treatment-resistant major depressive disorder (MDD). Method Thirty-three subjects with DSM-IV-diagnosed MDD received a single open-label infusion of ketamine (0.5 mg/kg) and were rated at baseline and at 40, 80, 120, and 230 minutes postinfusion with the Scale for Suicide Ideation (SSI), the Montgomery-Åsberg Depression Rating Scale, the Hamilton Depression Rating Scale, and the Beck Depression Inventory. The study was conducted between October 2006 and January 2009. Results Suicidal ideation scores decreased significantly on the SSI as well as on the suicide subscales of other rating instruments within 40 minutes; these decreases remained significant through the first 4 hours postinfusion (P Conclusions Suicidal ideation in the context of MDD improved within 40 minutes of a ketamine infusion and remained improved for up to 4 hours postinfusion. Future studies with ketamine in suicidal ideation are warranted due to the potential impact on public health. Trial registration clinicaltrials.gov Identifier: NCT00088699.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The rapid-acting dissociative agent ketamine, which has shown its efficacy in treating depression, is known to increase BDNF levels (37, 38).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [38]
In the citing paper
“Extensive experience with human patients has established that ketamine exerts rapid, robust antidepressant, antianhedonic, and antisuicidal actions within two hours of administration that are sustained for at least seven days in patients with major depression following a single infusion or intranasal administration [129-133].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [131]
In the citing paper
“Recent studies report that ketamine also reduces suicide ideation, a major advance over typical antidepressants with low efficacy and delayed onset of action151,152.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [151]
In the citing paper
“Clinical studies have demonstrated that a single sub-anesthetic dose of the dissociative anesthetic ketamine induces rapid and sustained antidepressant actions in treatment-resistant patients.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [7]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationAssessment of suicidal intention: The Scale for Suicide Ideation.
Beck, A. T., Kovacs, M., & Weissman, A. (1979) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.47.2.343 · Cited by 3,419
Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.757 · Cited by 2,025
Assessment of Depression: The Depression Inventory
Beck, A. T., & Beamesderfer, A. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395074 · Cited by 1,832
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Cognitive Therapy for the Prevention of Suicide Attempts: A Randomized Controlled Trial
Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005) · JAMA · doi:10.1001/jama.294.5.563 · Cited by 1,045
Bremner, J. D., Krystal, J. H., Putnam, F. W., Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024465317902 · Cited by 817
Cited by
Items 501–570 of 570
Woodburn, S. C., Kuhn, A. M., Bosis, K. E., Dadosky, D. T., Mueller, E. J., Bollinger, J. L., Gonzalez, R. M. S., Robinson, J. E., Vollmer, L. L., & Wohleb, E. S. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106886 · Cited by 1
Manza, P., Belcher, A. M., Fitzsimons, H., Spaderna, M., Greenblatt, A. D., Smith, H. C., Derenoncourt, M., Gann, D. S., Farooq, U., Kvarta, M. D., et al. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2025.2541212 · Cited by 2
Self-citationRole of chemokines in depression: Highlights on CX 3 CL1/CX 3 CR1 signaling
Yin, Y., & Li, Y. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251389532 · Cited by 1
“Clinical and preclinical studies have shown that ketamine, a non-competitive N -methyl- d -aspartate acid receptor antagonist, produces rapid-onset antidepressant effects (DiazGranados et al., 2010; Yin et al., 2021).”
Comparative EEG analysis of the effects of ketamine enantiomers and metabolites in rhesus macaques
Iwamura, Y., Nishigori, K., Yamaguchi, M., Ogi, Y., Kobayashi, A., 岩崎, 剛., Nagata, H., & Ikeda, K. (2026) · Journal of Neurophysiology · doi:10.1152/jn.00203.2025 · Cited by 1
Antidepressant and Abuse Potential of Ketamine
Hasselmann, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00059-5 · Cited by 1
AMPA Receptor Potentiators as Potential Rapid-Acting Antidepressants
Garro-Martínez, E., & Adell, A. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_6 · Cited by 1
How ketamine helps to overcome depression
Huynh, T. N., & Klann, E. (2014) · eLife · doi:10.7554/elife.05418 · Cited by 1
“It can also reduce suicidal thoughts in individuals with treatment-resistant depression (DiazGranados et al., 2010).”
BackgroundKETAMINE FOR DEPRESSION: AN OLD DRUG WITH A NEW INDICATION
Schepisi, C., Sabatini, D., & Nencini, P. (2014) · Cited by 1
Ducasse, D., Girod, C., & Courtet, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_10 · Cited by 2
Monitoring, Evaluation, and Referral of Patients with Suicide Risk Upon Hospital Admission
Giner, L., Root, C. W., & Courtet, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_34 · Cited by 1
Psychotic depression and suicide risk: a mixed methods study
Fredriksen, K. J. (2022) · doi:10.31265/usps.218 · Cited by 1
Antidepressants: current mechanisms and new hopes
Greener, M. (2014) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2014.3.1.23 · Cited by 1
Rapidly acting treatment in the emergency department
Heller, R. A., & Byrne, L. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088077.033
Future perspectives on the pharmacological management of depression
Yates, S., Smith, E., Alhaj, H. A., & McAllister-Williams, H. (2013) · Clinical Investigation · doi:10.4155/cli.12.152
Sayar, G. H., Özten, E., & SAVAS, H. A. (2015) · Journal of Mood Disorders · doi:10.5455/jmood.20150130085334
Pain, Addiction, Depression (PAD): Assessment of Pain and Addiction, the Neurobiology of Pain
Hansen, H. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1951-2_41
Experimental Pharmacologic Approaches for the Reduction of Suicidal Ideation and Behavior
Ballard, E. D., Richards, E. M., Ionescu, D. F., Niciu, M. J., Voort, J. V., & Zarate, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09964-4_12
Self-citationPotential novel treatments for bipolar depression
Zarate, C. A., & Manji, H. K. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_12 · Cited by 1
Self-citationSpecific modalities of treatment
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.024
ACMDCouncil on the Misuse of Drugs
Sulaiman, Z., Street, M., & Featherstone, L. (2014)
(2016) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-114245
Glutamate Approaches Towards the Treatment of Mood Disorders
Jones, C. K., Conn, P. J., & Lindsley, C. W. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00258
Wide-scale comparison of transcriptome data and the role of microRNA in major depression and suicide
Lim, R. S. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0072309
“Dysregulation of several neurotransmitter systems in different brain regions have been suggested: the serotonergic [78, 81, 95, 113], dopimanergic [12, 85, 119], noradrenergic [11, 41, 59, 84, 96], glutamate [20, 23, 32, 33, 48, 52, 79] and GABAergic [18, 20, 57, 61, 74, 91, 99] systems.”
Ketamine: The Glutamatergic Antidepressant and Its Efficacy
Tracy, D. K., Caddy, C., & Shergill, S. S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_41
The Role of Intracellular Signaling Pathways in the Neurobiology of the Depressive Disorder.
Kim, S. H. (2011) · Saengmul jeongsin euihag/Saengmul jeongsin uihak
Serafini, G., Hayley, S. P., Ghasemi, M., & Amore, M. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch11
Increased Activity of GABA(A) Receptors Contributes to Postanesthetic Memory Deficits
Zurek, A. A. (2015) · TSpace (University of Toronto)
Nuwal, K., Jain, S., & Rathore, K. S. (2018) · Pharmatutor · doi:10.29161/pt.v6.i6.2018.24
“How to cite this article: Nuwal K, Jain S, Rathore KS; Ketamine: A Magic Remedy; PharmaTutor; 2018; 6(6); 24-27; http://dx.”
BackgroundPrefrontal gene expression changes in mood disorders and suicide
Zhao, J. (2018) · Data Archiving and Networked Services (DANS)
Nobile, B. (2018) · theses.fr (ABES) · doi:10.70675/87dba01cze0bez43bbz81bbz4aaaaf900c80 · Cited by 1
Ketamine for suicidal ideation treatment: Available evidence remains convincing
Bartoli, F., Crocamo, C., & Carrà, G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.01.020
Lee, J. C.-H. (2018) · TSpace (University of Toronto)
Goans, C. (2019) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1538660
Hales, C., Bartlett, J., Arban, R., Hengerer, B., & Robinson, E. S. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.22.915132
Subanesthetic IV ketamine reduces acute suicidal ideation in patients with mood disorders
Jenko, K. J., & Anzilotti, J. (2019) · JMU Scholoraly Commons (James Madison University)
Sun, Y. (2017) · TSpace (University of Toronto)
Rapidly Acting Treatment in the ED for Psychiatric Patients
Wilson, M. P., & Heller, R. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-52520-0_26
Caring for the Suicidal Person
Jimenez, A. L., Della, C. D., Arcenas, A. M. A., & Esling, K. T. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-62613-6_15
Emergence of Ketamine as a Rapid Acting Antidepressant: Mechanistic Insights and Future Directions
Singh, A., & Bedi, P. M. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.99765
Nitrous Oxide: An Old Compound with Emerging Psychotropic Properties
Kamel, L. Y., Quach, D. F., Gott, B. M., & Conway, C. R. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_4
Hardin, W. (2015) · Seton Hall University eRepository (Seton Hall University)
Potential Novel Treatments in Bipolar Depression
Machado‐Vieira, R., Henter, I. D., Manji, H. K., & Zarate, C. A. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_12
Self-citationKing, A., Greenberger, S., Prats, M., Boulger, C., Tyransky, A., Thompson, L., Kman, N. E., Leung, C., Mitzman, J. M., Barrie, M., et al. (2017) · Journal of Education and Teaching in Emergency Medicine · doi:10.5070/m523035690 · Cited by 1
Estudio post-mortem de las alteraciones en la expresión de RNA en el cerebro de pacientes suicidasPreprint
Cabrera‐Mendoza, B. (2020) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/cmvjb
Kalra, H., Dean, O. M., Dodd, S., & Berk, M. (2012) · doi:10.2217/ebo.11.273
Rawal, B., & Ballanyi, K. (2022) · Brain Sciences · doi:10.3390/brainsci12070945
Self-Harm and Danger to Others
Malouf, N., Jackson, B. F., & Borg, K. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-3548-2.00196-8 · Cited by 1
Jamal, S., Kar, S. K., & Singh, A. K. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100119
Reis, H. S. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.47.2024.tde-09042024-161136
Ahuja, J., & Leontieva, L. (2024) · Case Reports in Psychiatry · doi:10.1155/2024/2143372 · Cited by 1
“Although there have been reports of a quick reduction in thoughts of suicide [23] and a decrease in suicidal thinking following the administration of ketamine [24], it is possible that the increased suicidal thoughts experienced by certain vulnerable individuals were really caused by anxiety and…”
BackgroundGillespie, C. F., & Nemeroff, C. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00046-7
Uso da cetamina em saúde mental: uma revisão bibliométrica
Viana-Ferreira, K. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2024.tde-06022025-132449
Ketamine in the Treatment of Depression
Kaczmarska, U., Cioch, M. J., Nowak, J., Woźniak, A., Hermanowicz, K., Najdek, A., Oleksy, D., Komada, D., Doman, K., & Mycyk, M. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.78.57672
“%) who had a score ≥ 4 on the SSI before ketamine administration, all of these individuals had scores below 4 (9 dropped after 40 minutes, and 1 after 80 minutes) [43].”
Les troubles psychiatriques résistants
Holtzmann, J. (2015) · Presses universitaires de Grenoble eBooks · doi:10.3917/pug.bouv.2015.01.0135
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE
Cuomo, A. (2021) · Use Siena air (University of Siena) · doi:10.25434/alessandro-cuomo_phd2021
Ju, L., Yang, J., Zhu, T., Liu, P., & Yang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19367716
Ju, L., Yang, J., Zhu, T., Liu, P., & Yang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19367719
Ju, L., Yang, J., Zhu, T., Liu, P., & Yang, J. (2022) · Figshare · doi:10.6084/m9.figshare.19367713
Oswin, S. (2023) · ScholarWorks (Walden University) · Cited by 1
Aydın, Ş. (2019) · Dspace-ESOGU (Eskişehir Osmangazi University)
SLEEP AND MENTAL HEALTH: THE RELATIONSHIP BETWEEN SLEEP DISORDERS AND DEPRESSION
Strzelecka, A. A., Basak, A. E., Khiralla-Gawlik, S., Kwiatkowska, A., Teper, K., Świercz, P., Mączka, E., Strużek, K., & Tracz, W. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3670
Parésys, L. (2015) · theses.fr (ABES) · doi:10.70675/cb3a1f33z6c64z4692z91cez73d3c9db9fec
“Très récemment, la kétamine a été testée en injection intraveineuse aiguë sur des patients résistants aux antidépresseurs conventionnels (DiazGranados et al. 2010).”
BackgroundPotentialisation de la réponse antidépressive par la lumière : étude préclinique
Delcourte, S. (2019) · theses.fr (ABES) · doi:10.70675/7468b6d3zbf12z4888z88afzc63efcc91723
Prise en charge médicamenteuse des patients souffrant de douleur chronique réfractaire
Corriger, A. (2019) · theses.fr (ABES) · doi:10.70675/668e4777zf8d0z4bdcz9780z0f91fedfe2b6
Xia, M., Duan, J., Chen, N., Zhou, W., Zhang, N., Feng, M., Sun, Y., & Luan, Y. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s580802
“A comparative perspective with ketamine, the established rapid-acting antidepressant, 119 helps define lidocaine’s potential niche.”
Yang, J., Huang, T., Wang, M., Yingrui, X., Xuan, L., Li, C., Cao, W., Liyan, H., & Zhou, H. M. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.07.016 · Cited by 1
“Since then, accumulating evidence confirmed that a single low dose of ketamine induces rapid antidepressant effects within hours that can persist for approximately one week (Diazgranados et al., 2010; Fuku-moto and Chaki, 2015; Rawat et al., 2022).”
Louka, P., Pitsillides, A. A., Koumas, M., Papacharalambous, C., Sophocleous, A., & Zanos, P. (2026) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyag044
Borkowska, M., Witaszczyk, M., Sołtan, A., Wiktorzak, N., Lipska, J., Prządka, J., Kochan-Olszewska, D., Rudnicki, L., Pawlicki, J., Laskus, J., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6636
Uso de cetamina na depressão grave e risco suicida: Desfechos clínicos e segurança
Gasparotto, N. D., Teixeira, N. A. P., Bandeira, H. L., Rosolen, I. C., & Silva, J. R. J. (2026) · Fisioterapia Brasil · doi:10.62827/fb.v27i9.1357
Metadata
- Authors
- DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Corresponding author
- Zarate, Carlos A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-07-13
- Volume
- 71
- Issue
- 12
- Pages
- 1605-1611
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC3012738
- OpenAlex
- W2103255996
- Cited by
- 564
- References
- 41
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 22 · 2023: 21 · 2022: 41 · 2021: 41 · 2020: 39 · 2019: 35 · 2018: 49 · 2017: 33 · 2016: 51 · 2015: 59 · 2014: 52 · 2013: 40 · 2012: 30
- FWCI
- 23.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 MH999999)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- suicidal ideation, ketamine, NMDA receptor antagonists, rapid antidepressant effects, single-dose infusion, hopelessness, anxiety, depression
- MeSH terms
- Adult, Antidepressive Agents, Depression, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Infusions, Intravenous, Ketamine, Male, Middle Aged, Psychiatric Status Rating Scales, Time Factors, N-Methylaspartate, Treatment Outcome, Excitatory Amino Acid Antagonists, Diagnostic and Statistical Manual of Mental Disorders, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.